Just found another article by same person published very recently on Jan 1st 2016,
He mentioned below,
"As I mentioned, there were a few companies that I got very wrong. Anatara (ASX : ANR) and Oncosil (ASX : OSL) are the two standouts, along with Imuron (ASX : IMC) and ResApp (ASX : RAP). I don’t consider any of these companies to be investment-worthy and so I would never have put my hard-earned cash into any of them anyhow. But obviously other people did, and did very well in some instances."
Resapp - a sceptic's view., page-6
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?